1. Home
  2. SGRP vs FEMY Comparison

SGRP vs FEMY Comparison

Compare SGRP & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGRP
  • FEMY
  • Stock Information
  • Founded
  • SGRP 1967
  • FEMY 2004
  • Country
  • SGRP United States
  • FEMY United States
  • Employees
  • SGRP N/A
  • FEMY N/A
  • Industry
  • SGRP Business Services
  • FEMY Medical/Dental Instruments
  • Sector
  • SGRP Consumer Discretionary
  • FEMY Health Care
  • Exchange
  • SGRP Nasdaq
  • FEMY Nasdaq
  • Market Cap
  • SGRP 24.5M
  • FEMY 28.3M
  • IPO Year
  • SGRP 1996
  • FEMY 2021
  • Fundamental
  • Price
  • SGRP $1.05
  • FEMY $0.98
  • Analyst Decision
  • SGRP
  • FEMY Strong Buy
  • Analyst Count
  • SGRP 0
  • FEMY 3
  • Target Price
  • SGRP N/A
  • FEMY $8.67
  • AVG Volume (30 Days)
  • SGRP 39.5K
  • FEMY 557.5K
  • Earning Date
  • SGRP 08-13-2025
  • FEMY 08-07-2025
  • Dividend Yield
  • SGRP N/A
  • FEMY N/A
  • EPS Growth
  • SGRP N/A
  • FEMY N/A
  • EPS
  • SGRP N/A
  • FEMY N/A
  • Revenue
  • SGRP $196,814,000.00
  • FEMY $1,699,232.00
  • Revenue This Year
  • SGRP N/A
  • FEMY $231.84
  • Revenue Next Year
  • SGRP N/A
  • FEMY $245.28
  • P/E Ratio
  • SGRP N/A
  • FEMY N/A
  • Revenue Growth
  • SGRP N/A
  • FEMY 61.97
  • 52 Week Low
  • SGRP $1.00
  • FEMY $0.69
  • 52 Week High
  • SGRP $2.48
  • FEMY $1.80
  • Technical
  • Relative Strength Index (RSI)
  • SGRP 41.98
  • FEMY 55.24
  • Support Level
  • SGRP $1.03
  • FEMY $0.85
  • Resistance Level
  • SGRP $1.08
  • FEMY $1.10
  • Average True Range (ATR)
  • SGRP 0.04
  • FEMY 0.08
  • MACD
  • SGRP 0.00
  • FEMY 0.02
  • Stochastic Oscillator
  • SGRP 16.67
  • FEMY 63.50

About SGRP SPAR Group Inc.

SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: